Ameliorating Mitochondrial Dysfunction for the Therapy of Parkinson's Disease

Qing Zheng,Hanghang Liu,Yifan Gao,Guozhi Cao,Yusong Wang,Zhen Li
DOI: https://doi.org/10.1002/smll.202311571
IF: 13.3
2024-02-23
Small
Abstract:Mitochondrial dysfunction can cause and accelerate the pathogenesis of Parkinson's disease (PD). The study comprehensively reviews advanced strategies of ameliorating mitochondrial dysfunction for PD therapy, including 1) scavenge mitochondrial ROS; 2) enhance mitochondrial autophagy; 3) promote mitochondrial biogenesis; 4) transplant healthy mitochondria; 5) photo‐biomodulate mitochondria; 6) do exercise for improving mitochondrial quality. These strategies show excellent therapeutic effect on PD. Parkinson's disease (PD) is currently the second most incurable central neurodegenerative disease resulting from various pathogenesis. As the "energy factory" of cells, mitochondria play an extremely important role in supporting neuronal signal transmission and other physiological activities. Mitochondrial dysfunction can cause and accelerate the occurrence and progression of PD. How to effectively prevent and suppress mitochondrial disorders is a key strategy for the treatment of PD from the root. Therefore, the emerging mitochondria‐targeted therapy has attracted considerable interest. Herein, the relationship between mitochondrial dysfunction and PD, the causes and results of mitochondrial dysfunction, and major strategies for ameliorating mitochondrial dysfunction to treat PD are systematically reviewed. The study also prospects the main challenges for the treatment of PD.
materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology
What problem does this paper attempt to address?